315 related articles for article (PubMed ID: 17363604)
1. Betulinic acid inhibits prostate cancer growth through inhibition of specificity protein transcription factors.
Chintharlapalli S; Papineni S; Ramaiah SK; Safe S
Cancer Res; 2007 Mar; 67(6):2816-23. PubMed ID: 17363604
[TBL] [Abstract][Full Text] [Related]
2. Betulinic acid inhibits colon cancer cell and tumor growth and induces proteasome-dependent and -independent downregulation of specificity proteins (Sp) transcription factors.
Chintharlapalli S; Papineni S; Lei P; Pathi S; Safe S
BMC Cancer; 2011 Aug; 11():371. PubMed ID: 21864401
[TBL] [Abstract][Full Text] [Related]
3. Tolfenamic acid and pancreatic cancer growth, angiogenesis, and Sp protein degradation.
Abdelrahim M; Baker CH; Abbruzzese JL; Safe S
J Natl Cancer Inst; 2006 Jun; 98(12):855-68. PubMed ID: 16788159
[TBL] [Abstract][Full Text] [Related]
4. Transient activation of EGFR/AKT cell survival pathway and expression of survivin contribute to reduced sensitivity of human melanoma cells to betulinic acid.
Qiu L; Wang Q; Di W; Jiang Q; Schefeller E; Derby S; Wanebo H; Yan B; Wan Y
Int J Oncol; 2005 Sep; 27(3):823-30. PubMed ID: 16077934
[TBL] [Abstract][Full Text] [Related]
5. Betulinic acid decreases ER-negative breast cancer cell growth in vitro and in vivo: role of Sp transcription factors and microRNA-27a:ZBTB10.
Mertens-Talcott SU; Noratto GD; Li X; Angel-Morales G; Bertoldi MC; Safe S
Mol Carcinog; 2013 Aug; 52(8):591-602. PubMed ID: 22407812
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of NFkappaB and pancreatic cancer cell and tumor growth by curcumin is dependent on specificity protein down-regulation.
Jutooru I; Chadalapaka G; Lei P; Safe S
J Biol Chem; 2010 Aug; 285(33):25332-44. PubMed ID: 20538607
[TBL] [Abstract][Full Text] [Related]
7. Betulinic acid targets YY1 and ErbB2 through cannabinoid receptor-dependent disruption of microRNA-27a:ZBTB10 in breast cancer.
Liu X; Jutooru I; Lei P; Kim K; Lee SO; Brents LK; Prather PL; Safe S
Mol Cancer Ther; 2012 Jul; 11(7):1421-31. PubMed ID: 22553354
[TBL] [Abstract][Full Text] [Related]
8. Aspirin inhibits colon cancer cell and tumor growth and downregulates specificity protein (Sp) transcription factors.
Pathi S; Jutooru I; Chadalapaka G; Nair V; Lee SO; Safe S
PLoS One; 2012; 7(10):e48208. PubMed ID: 23110215
[TBL] [Abstract][Full Text] [Related]
9. Celastrol suppresses angiogenesis-mediated tumor growth through inhibition of AKT/mammalian target of rapamycin pathway.
Pang X; Yi Z; Zhang J; Lu B; Sung B; Qu W; Aggarwal BB; Liu M
Cancer Res; 2010 Mar; 70(5):1951-9. PubMed ID: 20160026
[TBL] [Abstract][Full Text] [Related]
10. Betulinic acid decreases specificity protein 1 (Sp1) level via increasing the sumoylation of sp1 to inhibit lung cancer growth.
Hsu TI; Wang MC; Chen SY; Huang ST; Yeh YM; Su WC; Chang WC; Hung JJ
Mol Pharmacol; 2012 Dec; 82(6):1115-28. PubMed ID: 22956772
[TBL] [Abstract][Full Text] [Related]
11. Betulinic acid selectively increases protein degradation and enhances prostate cancer-specific apoptosis: possible role for inhibition of deubiquitinase activity.
Reiner T; Parrondo R; de Las Pozas A; Palenzuela D; Perez-Stable C
PLoS One; 2013; 8(2):e56234. PubMed ID: 23424652
[TBL] [Abstract][Full Text] [Related]
12. Drugs that target specificity proteins downregulate epidermal growth factor receptor in bladder cancer cells.
Chadalapaka G; Jutooru I; Burghardt R; Safe S
Mol Cancer Res; 2010 May; 8(5):739-50. PubMed ID: 20407012
[TBL] [Abstract][Full Text] [Related]
13. Combining betulinic acid and mithramycin a effectively suppresses pancreatic cancer by inhibiting proliferation, invasion, and angiogenesis.
Gao Y; Jia Z; Kong X; Li Q; Chang DZ; Wei D; Le X; Suyun H; Huang S; Wang L; Xie K
Cancer Res; 2011 Aug; 71(15):5182-93. PubMed ID: 21673052
[TBL] [Abstract][Full Text] [Related]
14. Curcumin decreases specificity protein expression in bladder cancer cells.
Chadalapaka G; Jutooru I; Chintharlapalli S; Papineni S; Smith R; Li X; Safe S
Cancer Res; 2008 Jul; 68(13):5345-54. PubMed ID: 18593936
[TBL] [Abstract][Full Text] [Related]
15. Suppression of STAT3 and HIF-1 alpha mediates anti-angiogenic activity of betulinic acid in hypoxic PC-3 prostate cancer cells.
Shin J; Lee HJ; Jung DB; Jung JH; Lee HJ; Lee EO; Lee SG; Shim BS; Choi SH; Ko SG; Ahn KS; Jeong SJ; Kim SH
PLoS One; 2011; 6(6):e21492. PubMed ID: 21731766
[TBL] [Abstract][Full Text] [Related]
16. Betulinic acid inhibits the expression of hypoxia-inducible factor 1alpha and vascular endothelial growth factor in human endometrial adenocarcinoma cells.
Karna E; Szoka L; Palka JA
Mol Cell Biochem; 2010 Jul; 340(1-2):15-20. PubMed ID: 20174965
[TBL] [Abstract][Full Text] [Related]
17. Discovery of betulinic acid as a selective inhibitor of human melanoma that functions by induction of apoptosis.
Pisha E; Chai H; Lee IS; Chagwedera TE; Farnsworth NR; Cordell GA; Beecher CW; Fong HH; Kinghorn AD; Brown DM
Nat Med; 1995 Oct; 1(10):1046-51. PubMed ID: 7489361
[TBL] [Abstract][Full Text] [Related]
18. Pharmacologic doses of ascorbic acid repress specificity protein (Sp) transcription factors and Sp-regulated genes in colon cancer cells.
Pathi SS; Lei P; Sreevalsan S; Chadalapaka G; Jutooru I; Safe S
Nutr Cancer; 2011; 63(7):1133-42. PubMed ID: 21919647
[TBL] [Abstract][Full Text] [Related]
19. Betulinic acid suppresses constitutive and TNFalpha-induced NF-kappaB activation and induces apoptosis in human prostate carcinoma PC-3 cells.
Rabi T; Shukla S; Gupta S
Mol Carcinog; 2008 Dec; 47(12):964-73. PubMed ID: 18444250
[TBL] [Abstract][Full Text] [Related]
20. Betulinic acid treatment promotes apoptosis in hepatoblastoma cells.
Eichenmüller M; von Schweinitz D; Kappler R
Int J Oncol; 2009 Oct; 35(4):873-9. PubMed ID: 19724925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
